Wockhardt Limited
WOCKPHARMA
Xếp hạng trong cổ phiếu
#4670
Wockhardt Limited, together with its subsidiaries, operates as a pharmaceutical... Wockhardt Limited, together with its subsidiaries, operates as a pharmaceutical and biotech company, in India, the United States, the United Kingdom, Switzerland, Ireland, Russia, Europe, and internationally. It manufactures and trades pharmaceuticals, medicinal chemical, and botanical products, as well as chemicals and chemical products. The company also develops its flagship antibiotic, ZAYNICH zidebactam/cefepime, a novel beta lactam enhancer mechanism for the treatment of sepsis and hospital/ventilator associated pneumonia; FOVISCU, an antibiotic for gram-negative infections; MIQNAF nafithromycin, which targets azithromycin-resistant community respiratory pathogens; and ODRATE, a once-daily combination of ertapenem and zidebactam for resistant gram-negative infections through outpatient parenteral antimicrobial therapy. In addition, it develops and commercializes insulin analogs, glucagon-like peptide-1 agonists, and novel combination drug products; Biovac-B, a recombinant hepatitis-B vaccine; Wepox, a recombinant human erythropoietin; Wosulin, a recombinant human insulin; and Glaritus, a recombinant insulin glargine. Further, the company offers delivery devices for insulin, including Dispopen disposable pen and Mypen reusable pen. Wockhardt Limited was founded in 1967 and is headquartered in Mumbai, India.
Giá cổ phiếu
$19.63
Vốn hóa thị trường
$3.19B
Thay đổi (1 ngày)
-5.40%
Thay đổi (1 năm)
25.85%
Quốc gia
IN
Giao dịch Wockhardt Limited (WOCKPHARMA)
Danh mục
Healthcare
Lịch sử giá cổ phiếu của Wockhardt Limited (WOCKPHARMA)
Giá đóng cửa cao nhất: $21.97 vào 2026-10-01
Giá đóng cửa thấp nhất: $5.42 vào 2000-02-01
Giá đóng cửa thấp nhất: $5.42 vào 2000-02-01
Lịch sử giá cổ phiếu của Wockhardt Limited từ 2000 đến 2026
Hiệu suất giá cổ phiếu hàng năm
| Năm | Hiệu suất |
|---|---|
| 2026 (TTM) | 16.12% |
| 2025 | -8.59% |
| 2024 | 260.79% |
| 2023 | 69.56% |
| 2022 | -45.77% |
| 2021 | -17.40% |
| 2020 | 94.38% |
| 2019 | -52.30% |
| 2018 | -40.76% |
| 2017 | 21.94% |
| 2016 | -58.62% |
| 2015 | 54.74% |
| 2014 | 138.08% |
| 2013 | -77.77% |
| 2012 | 352.82% |
| 2011 | -17.27% |
| 2010 | 111.82% |
| 2009 | 75.19% |
| 2008 | -79.38% |
| 2007 | 30.35% |
| 2006 | -18.10% |
| 2005 | 21.47% |
| 2004 | 52.62% |
| 2003 | 71.77% |
| 2002 | -10.48% |
| 2001 | 12.71% |
| 2000 | 0.00% |
Giá cổ phiếu của các công ty hoặc đối thủ tương tự
| Công ty | Giá cổ phiếu | Thay đổi 1năm% | Quốc gia |
|---|---|---|---|
| $63.27 | 71.74% |
US
|
|
| $45.68 | 36.02% |
SE
|
|
| $172.50 | 24.72% |
FR
|
|
| $59.52 | -0.48% |
IT
|
|
| $110.74 | 50.36% |
US
|
